Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer

Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer

US Patent 5985877 · Granted Nov 16, 1999

Estimated economic value: $10,823,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Albumin-proaerolysin prodrugs2021
Albumin-proaerolysin prodrugs2020
Tumor activated prodrugs2015
Tumor activated prodrugs2014
Methods and compositions for the detection of cancer2014
Activation of peptide prodrugs by hK22014
Activation of peptide prodrugs by hK22013
Activation of peptide prodrugs by hK22011
Proaerolysin containing protease activation sequences and methods of use for tre2010
Tissue specific prodrugs2010
Proaerolysin containing protease activation sequences and methods of use for tre2010
Tumor activated prodrugs2009